FDA.reportPublic FDA data

Crotalidae immune F(ab')2 (equine) 120 MG Injection

RxCUI
2101275
RxNorm name
Crotalidae immune F(ab')2 (equine) 120 MG Injection
Display name
Crotalidae immune F(ab')2 (equine) 120 MG Injection
Full name
Crotalidae immune F(ab')2 (equine) 120 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125488AnavipCrotalidae Immune F(ab')2 (Equine)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a16596a5-e87e-40c2-8e34-cea5839849c3Crotalidae immune F(ab')2 (equine) 120 MG Injection [PSN] · Crotalidae immune F(ab')2 (equine) 120 MG Injection [SCD]224These highlights do not include all the information needed to use ANAVIP safely and effectively. See full prescribing information for ANAVIP. ANAVIP (R) crotalidae immune F(ab') 2 (equine) Lyophilized Powder for Solution for Injection For Intravenous Use Only Initial U.S. Approval: 201520260123